Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer withdraws sickle cell drug Oxbryta
Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed up trials of new experimental rivals, Wall Street analysts said.
Pfizer pulls sickle cell treatment Oxbryta off global markets
The company said benefits no longer outweighed the risks, with data suggesting the drug might increase the risk of pain crises and "fatal events."
Pfizer to Withdraw Sickle Cell Drug Oxbryta Lots from World-Wide Markets
The healthcare company said clinical data indicates the overall benefit of Oxbryta no longer outweighs the risk in the approved sickle cell patient population.
1d
on MSN
FDA alerts patients about Pfizer's Oxbryta withdrawal
The U.S. Food and Drug Administration on Thursday alerted patients and healthcare professionals about the withdrawal of ...
STAT
1d
Sickle cell community scrambles to find safe plan after a drug is pulled from the market
After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left ...
3d
Pfizer to Withdraw Sickle-Cell Drug Oxbryta From Worldwide Markets
The healthcare company said clinical data indicates the overall benefit of Oxbryta no longer outweighs the risk in the ...
devdiscourse
1d
Today’s Health Roundup: Schizophrenia Breakthrough and Bird Flu Vaccination Pressures
This health news roundup covers significant advances and alerts, including the approval of Bristol Myers' new schizophrenia ...
Yahoo Finance
1d
Pharma Stock Roundup: JNJ's 3rd Talc-Related Bankruptcy Filing & More
Pfizer PFE said it is withdrawing its sickle-cell drug (“SCD”) drug,
Oxbryta
from worldwide markets. Merck’s MRK Keytruda ...
STAT
1d
Biotech’s real estate market is still upside down
Medicare’s controversial decision to condition coverage for even fully approved Alzheimer’s drugs is here to stay, per a top ...
devdiscourse
1d
Major Developments in Health Sector: New Drugs and Global Initiatives
The U.S. FDA approved Bristol Myers' new schizophrenia drug, the first of its kind in decades. Bavarian Nordic signed an ...
2d
European Union watchdog puts sickle cell disease drug on ice
European Union suspends Pfizer's Oxbryta for sickle cell disease due to safety concerns, urging doctors to stop use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Pfizer
Sickle cell disease
Feedback